The preliminary public providing of Fabtech Applied sciences was absolutely subscribed on Thursday. In line with BSE knowledge, buyers have utilized for 1,21,11,225 shares towards the 1,20,60,000 shares on supply.

Fabtech Applied sciences, a biopharma engineering firm, launched an preliminary public providing (IPO) to lift over Rs 200 crore from the first market.

The gray market premium (GMP) for the IPO stays in focus because the mainboard situation concludes its subscription at present.

After a subdued subscription, the gray market premium for the mainboard situation has remained flat forward of the subscription on day 3.

Right here’s a take a look at the gray market premium (GMP) and different particulars of the Fabtech Applied sciences IPO as subscription enters the ultimate day.